Michael Morin
Président chez NCI Experimental Therapeutics Program
Profil
Michael J.
Morin is currently the Chairman of the Drug Discovery Initiative at the Children's Tumor Foundation and Co-Chairman at the NCI Experimental Therapeutics Program.
He previously worked as the Chief Executive Officer at Supportive Therapeutics, Vice President of Global Research & Development at Pfizer Inc., Chief Scientific Officer at Immunome, Inc., and Chief Scientific Officer at Onkaido Therapeutics LLC.
Morin holds a doctorate degree from the State University of New York at Buffalo and an undergraduate degree from the University of Lowell.
Postes actifs de Michael Morin
| Sociétés | Poste | Début |
|---|---|---|
| NCI Experimental Therapeutics Program | Président | - |
| Children's Tumor Foundation | Corporate Officer/Principal | - |
Anciens postes connus de Michael Morin
| Sociétés | Poste | Fin |
|---|---|---|
Onkaido Therapeutics LLC
 Onkaido Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Moderna, Inc., Onkaido Therapeutics LLC offers advancement of oncology products for previously undruggable targets and as a superior alternative to existing drug modalities. The company is based in Cambridge, MA. | Directeur Technique/Scientifique/R&D | 01/09/2015 |
| Supportive Therapeutics | Directeur Général | 01/12/2014 |
| PFIZER, INC. | Directeur Technique/Scientifique/R&D | - |
| IMMUNOME, INC. | Directeur Général | 01/05/2019 |
Formation de Michael Morin
| State University of New York at Buffalo | Doctorate Degree |
| University of Lowell | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| IMMUNOME, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
| Children's Tumor Foundation | Miscellaneous |
| Supportive Therapeutics | |
Onkaido Therapeutics LLC
Onkaido Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Moderna, Inc., Onkaido Therapeutics LLC offers advancement of oncology products for previously undruggable targets and as a superior alternative to existing drug modalities. The company is based in Cambridge, MA. | Health Technology |
| NCI Experimental Therapeutics Program |
